RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Comprehensive Financial Management LLC's Holding History (CIK: 0001799802)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 941,895 Value ($000) $3,852 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 941,895 Value ($000) $4,596 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 941,895 Value ($000) $4,766 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 941,895 Value ($000) $4,983 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 941,895 Value ($000) $6,367 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 941,895 Value ($000) $6,207 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 941,895 Value ($000) $7,064 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 941,895 Value ($000) $9,391 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 941,895 Value ($000) $9,287 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 941,895 Value ($000) $7,205 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 1,109,395 Value ($000) $8,287 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 1,109,395 Value ($000) $7,400 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 1,109,395 Value ($000) $8,553 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 1,109,395 Value ($000) $11,804 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 1,109,395 Value ($000) $9,030 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 1,109,395 Value ($000) $7,943 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 1,109,395 Value ($000) $19,004 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 1,109,395 Value ($000) $25,527 Avg Close $28.34 Range $17.80 - $42.81
Q2 2021
Shares 1,109,395 Value ($000) $40,493 Avg Close $29.60 Range $19.68 - $38.39